Importantly, our integrative functional genomics indicated that T-/B-cell development-related RAG1 may impact TACE efficiency via regulating antitumor immunity in HCC, and RAG1 may be a target to improve therapeutic strategy for unresectable HCC patients. Here, RAG1 is linked to hepatocellular carcinoma.